z-logo
open-access-imgOpen Access
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results
Author(s) -
Tetsuji Terazawa,
Takeshi Kato,
Masahiro Goto,
Katsuya Ohta,
Hironaga Satake,
Shingo Noura,
Yoshinori Kagawa,
Hisato Kawakami,
Hiroko Hasegawa,
Kazuhiro Yanagihara,
Tatsushi Shingai,
Ken Nakata,
Masahito Kotaka,
Masayuki Hiraki,
Ken Konishi,
Shiro Nakae,
Daisuke Sakai,
Yukinori Kurokawa,
Toshio Shimokawa,
Toshimasa Tsujinaka,
Taroh Satoh
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac145
Subject(s) - medicine , panitumumab , colorectal cancer , chemotherapy , rectum , gastroenterology , phases of clinical research , oncology , progression free survival , clinical trial , splenic flexure , cancer , colonoscopy , kras

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom